Saudiarabicains A-E, bioactive 19-acetoxyingol diterpenoids from Euphorbia saudiarabica

https://doi.org/10.1016/j.tetlet.2020.152203Get rights and content

Highlights

  • New saudiarabicains were isolated from aerial parts of Euphorbia saudiarabica.

  • Saudiarabicains A-E are 19-acetoxyingol diterpenoids.

  • Saudiarabicains inhibited activity of α-glucosidase.

  • Saudiarabicains inhibited activity of P-glycoprotein.

Abstract

Five new 19-acetoxyingols were isolated from the aerial parts of Euphorbia saudiarabica. They included two uncommon pentacyclic acetoxyingols (1, 2) and two 2,3-diepimers (3, 4), representing the first report of 19-acetoxyingols epimers. Their structures were determined by analysis of extensive 1D and 2D NMR spectroscopic data. The absolute configurations were established by experimental and calculated CD analysis. Compounds 35 showed α-glucosidase inhibitory effects superior to the positive control, acarbose (IC50 9.1, 8.0, 1.8 vs 147 µM, respectively). Compounds 1, 2, 4, and 5 showed inhibitory effects on human P-glycoprotein comparable to the positive control, valspodar (IC50 0.1–1.4 vs 0.2 µM, respectively).

Introduction

The Euphorbia L. (Euphorbiaceae) genus has been extensively studied and its members are reported to produce a wide diversity of diterpenoids [1], [2] with a wide range of biological activities including anti-α-glucosidase [3], anti-multidrug resistance [4], anti-HIV [5], anti-inflammatory [6] and anti-microbial [7]. Euphorbia saudiarabica, first identified in 2007, is endemic to Saudi Arabia distributed in its southwestern parts close to the Red Sea [8]. To date, there has been no previously reported phytochemical investigation of E. saudiarabica.

Ingol-type diterpenoids are tetracyclic diterpenoids produced only by members of the Euphorbia genus and they are most commonly found with a C-19 methyl group [3], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21]. Among these ingol diterpenoids, only twelve are found as epimers (at C-2 and C-3) [18], [14], [15], [16]. Furthermore, C-19 oxygenated ingol diterpenoids are very uncommon with only nine of these compounds reported [10], [11], [13], [22], [23] among which only one pentacyclic 19-acetoxyingol has been previously reported [11]. Herein, we report the structure elucidation and biological evaluations of five new 19-acetoxyingols from the aerial parts of E. saudiarabica. The structures of the compounds were established by extensive NMR spectroscopic data and their absolute configurations by experimental and calculated CD analysis. The isolates were evaluated for inhibitory effects against yeast α-glucosidase enzyme and human P-glycoprotein (P-gp) activities and for cytotoxicity effects against murine and human skin cancer cell lines.

Section snippets

Results and discussion

Five new 19-acetoxyingols were isolated and identified from the aerial parts of E. saudiarabica, two of which are pentacyclic (1 and 2), and two of which are 2,3-diepimers (3 and 4), representing the first report of 19-acetoxyingols epimers (Fig. 1).

Saudiarabicain A (1) was obtained as a white amorphous solid, with a molecular formula C31H40O11 as deduced by ESI-TOF-MS (m/z 611.2473 [M + Na]+, calcd. for C31H40O11Na, 611.2473), corresponding to 12 degrees of unsaturation. The 1H and 13C NMR

Conclusion

In summary, five new 19-acetoxyingol type diterpenoids including two pentacyclic (1 and 2) and two 2,3-diepimers (3 and 4) were isolated and identified from the aerial parts of E. saudiarabica. Their absolute configurations were established by experimental and calculated CD analysis. Compounds 35 showed yeast α-glucosidase inhibitory effects and compounds 1, 2, 4, and 5 showed human P-glycoprotein inhibitory effects.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

Research reported in this publication was made possible by the use of equipment and services available through the RI-INBRE Centralized Research Core Facility which is supported by the Institutional Development Award (IDeA) Network for Biomedical Research Excellence from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103430.

References (26)

  • J.R. Hanson et al.

    Nat. Prod. Rep.

    (2019)
  • D. Lu et al.

    Fitoterapia

    (2014)
  • Z.-H. Xu et al.

    Phytochemistry

    (1998)
  • H.J. Opferkuch et al.

    Tetrahedron Lett.

    (1973)
  • L.-J. Lin et al.

    Phytochemistry

    (1983)
  • M.O. Fatope et al.

    Bioorg. Med. Chem.

    (1996)
  • T. Morgenstern et al.

    Phytochemistry

    (1996)
  • J.A. Marco et al.

    Phytochemistry

    (1997)
  • S.L. Yan et al.

    Phytochemistry

    (2018)
  • S.Y. Wang et al.

    J. Asian Nat. Prod. Res.

    (2019)
  • J.A. Marco et al.

    Phytochemistry

    (1998)
  • Y.L. Wei et al.

    J. Asian Nat. Prod. Res.

    (2018)
  • M. Jadranin et al.

    Phytochemistry

    (2013)
  • Cited by (5)

    • Phytochemical and pharmacological review of diterpenoids from the genus Euphorbia Linn (2012–2021)

      2022, Journal of Ethnopharmacology
      Citation Excerpt :

      Compounds (264, 229 and 260) at 20 μM was able to reverse MDR of HepG2/ADR cells to adriamycin (reversal fold: 10.05–448.39) (Yang et al., 2020). Compounds (236–237, 251 and 214) showed inhibitory effects on human P-gp comparable to the positive control, IC50 0.1–1.4 vs 0.2 mM, respectively (Bin Muhsinah et al., 2020). Euphosquamosin B (527) and euphosquamosin C (516) isolated from E. squamosa strongly inhibited the drug-efflux activity of the primary ABC-transporter Ca Cdr1p, an effect that translated, in a yeast strain overexpressing this transporter, into an increased sensitivity to fluconazole (Rawal et al., 2014).

    View full text